Cellebrite: Stronger Fundamentals Support A Buy Rating (NASDAQ:CLBT)
· seekingalpha.com
Cellebrite (CLBT) remains a buy as fundamentals strengthen, with FedRAMP High achieved and federal demand reaccelerating.
I gave a buy rating to Cellebrite ( CLBT ) previously, with my key thesis being that the federal demand issue looked more like a timing problem than a structura...